{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:31:46Z","timestamp":1793028706846,"version":"4.5.0"},"reference-count":83,"publisher":"Bentham Science Publishers Ltd.","issue":"7","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"name":"University of Health Science Scientific Research Projects Unit","award":["2021\/129"],"award-info":[{"award-number":["2021\/129"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>This study aims to enhance the oral bioavailability of Nadolol (NDL), a \u03b2-blocker\nused in the management of hypertension, by incorporating it into a liposome-based delivery system. To\nimprove the formulation\u2019s stability, mucoadhesion, and permeability, chitosan coating was applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Liposomes were prepared via the ethanol injection method using soy phosphatidylcholine and\ndiacetyl phosphate. Chitosan coating was applied by adding chitosan solution (1% v\/v acetic acid) at different\nchitosan-to-lipid ratios (0.1-0.4 w\/w). The optimal formulation was selected based on particle size, PDI, and\nzeta potential. Characterization included encapsulation efficiency, drug loading, enzymatic stability, drug\nrelease, and Caco-2-based cytotoxicity and permeability assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The particle size and polydispersity index of the optimized formulations, L1-NDL, L2-NDL,\nL1C-NDL, and L2C-NDL, were measured as 27.02 \u00b1 0.18 nm, 24.55 \u00b1 0.22 nm, 160.10 \u00b1 3.17 nm, 161.00 \u00b1\n2.30 nm, 0.39 \u00b1 0.01, 0.37 \u00b1 0.01, 0.19 \u00b1 0.01, and 0.18 \u00b1 0.02. Encapsulation efficiencies of 56.01 \u00b1 3.70%\nand 43.87 \u00b1 1.24% were recorded for L1C-NDL and L2C-NDL, respectively, while drug loading capacities\nwere 61.47 \u00b1 2.03% and 67.80 \u00b1 0.74%, respectively. In an enzymatic degradation study, it was found that\nchitosan coating increased the stability of liposomes in the gastric media. The in vitro release was higher at\nboth pH 1.2 and 6.8. Caco-2 assays confirmed &gt;95% cell viability and enhanced permeability in the apical-tobasolateral\ndirection. In the permeability study, chitosan-coated liposomal formulations demonstrated\nenhanced transport in the apical-to-basolateral direction, indicating improved intestinal permeability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Chitosan-coated liposomes improved NDL\u2019s stability and permeability, showing promise as an\neffective oral delivery system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113816128401910250706133608","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T04:36:24Z","timestamp":1752813384000},"page":"556-567","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of Chitosan-Coated Liposomes for Oral Delivery of Nadolol: Preparation, Characterization, and in vitro Permeability Studies"],"prefix":"10.2174","volume":"32","author":[{"given":"Esra","family":"Ipekci","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, \u0130stanbul, 34000, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre Sefik","family":"Caglar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology Technology, Faculty of Pharmacy, University of Health Sciences, \u0130stanbul, 34000,Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Sinan","family":"Kaynak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Eski\u015fehir, 26000, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evren","family":"Gundogdu","sequence":"additional","affiliation":[{"name":"Department of Radiopharmacy, Faculty of Pharmacy, Ege University, \u0130zmir, 35000, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan \u00dcst\u00fcnda\u011f","family":"Okur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, \u0130stanbul, 34000, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2133\/dmpk.DMPK-12-RG-111","volume":"28","author":"Miyazaki N.","year":"2013","unstructured":"Miyazaki N.; Misaka S.; Ogata H.; Fukushima T.; Kimura J.; Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats. Drug Metab Pharmacokinet  2013,28(4),356-361","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","volume":"151","author":"Fumagalli C.","year":"2020","unstructured":"Fumagalli C.; Maurizi N.; Marchionni N.; Fornasari D.; \u03b2-blockers: Their new life from hypertension to cancer and migraine. Pharmacol Res  2020,151,104587","journal-title":"Pharmacol Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/jcpt.13764","volume":"47","author":"Kalsoom S.","year":"2022","unstructured":"Kalsoom S.; Zamir A.; Rehman A.; Clinical pharmacokinetics of nadolol: A systematic review. J Clin Pharm Ther  2022,47(10),1506-1516","journal-title":"J Clin Pharm Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"115412","DOI":"10.1016\/j.bcp.2023.115412","volume":"208","author":"Priviero F.","year":"2023","unstructured":"Priviero F.; Epigenetic modifications and fetal programming: Molecular mechanisms to control hypertension inheritance. Biochem Pharmacol  2023,208(115412),115412","journal-title":"Biochem Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"Mills K.T.","year":"2020","unstructured":"Mills K.T.; Stefanescu A.; He J.; The global epidemiology of hypertension. Nat Rev Nephrol  2020,16(4),223-237","journal-title":"Nat Rev Nephrol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.mpmed.2022.04.002","volume":"50","author":"Adeyeye E.","year":"2022","unstructured":"Adeyeye E.; Kapil V.; Lobo M.D.; Hypertension. Medicine  2022,50(7),399-407","journal-title":"Medicine"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cca.2016.12.014","volume":"465","author":"O\u2019Shea P.M.","year":"2017","unstructured":"O\u2019Shea P.M.; Griffin T.P.; Fitzgibbon M.; Hypertension: The role of biochemistry in the diagnosis and management. Clin Chim Acta  2017,465,131-143","journal-title":"Clin Chim Acta"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.1016\/j.heliyon.2023.e13258","volume":"9","author":"Ammann E.M.","year":"2023","unstructured":"Ammann E.M.; O\u2019Brien E.S.; Milentijevic D.; Characteristics, management, and blood pressure control in patients with apparent resistant hypertension in the US. Heliyon  2023,9(2),13258","journal-title":"Heliyon"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/B978-0-323-47871-7.00078-2","author":"Byrd J.B.","year":"2019","unstructured":"Byrd J.B.; Ram C.V.S.; Lerma E.V.; Pharmacologic treatment of hypertension. Nephrol Secrets  2019,477-482","journal-title":"Nephrol Secrets"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"122307","DOI":"10.1016\/j.molliq.2023.122307","volume":"385","author":"Volkova T.V.","year":"2023","unstructured":"Volkova T.V.; Simonova O.R.; Vigurskaya T.A.; Perlovich G.L.; Thermodynamics of solubility, distribution and permeability processes exemplified by nadolol - A beta-blocker drug with antianxiety potential. J Mol Liq  2023,385,122307","journal-title":"J Mol Liq"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","volume":"420","author":"Kawabata Y.","year":"2011","unstructured":"Kawabata Y.; Wada K.; Nakatani M.; Yamada S.; Onoue S.; Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm  2011,420(1),1-10","journal-title":"Int J Pharm"},{"key":"ref=12","first-page":"711","volume":"10","author":"Mozafari M.R.","year":"2005","unstructured":"Mozafari M.R.; Liposomes: An overview of manufacturing techniques. Cell Mol Biol Lett  2005,10(4),711-719","journal-title":"Cell Mol Biol Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"Sercombe L.","year":"2015","unstructured":"Sercombe L.; Veerati T.; Moheimani F.; Wu S.Y.; Sood A.K.; Hua S.; Advances and challenges of liposome assisted drug delivery. Front Pharmacol  2015,6,286","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"100132","DOI":"10.1016\/j.onano.2023.100132","volume":"11","author":"Nsairat H.","year":"2023","unstructured":"Nsairat H.; Alshaer W.; Odeh F.; Esawi E.; Khater D.; Al Bawab A.; Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. OpenNano  2023,11,100132","journal-title":"OpenNano"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-820466-5.00015-6","author":"Shukla R.","year":"2021","unstructured":"Shukla R.; Handa M.; Vasdev N.; Singh D.P.; Kesharwani P.; Nanomedicine in pain management. Theory Applications of Nonparenteral Nanomedicines  2021,355-382","journal-title":"Theory Applications of Nonparenteral Nanomedicines"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"Nsairat H.","year":"2022","unstructured":"Nsairat H.; Khater D.; Sayed U.; Odeh F.; Al Bawab A.; Alshaer W.; Liposomes: Structure, composition, types, and clinical applications. Heliyon  2022,8(5),09394","journal-title":"Heliyon"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1208\/s12249-022-02301-0","volume":"23","author":"Quadir S.S.","year":"2022","unstructured":"Quadir S.S.; Saharan V.; Choudhary D.; Harish ; Jain C.P.; Joshi G.; Nano-strategies as oral drug delivery platforms for treatment of cancer: Challenges and future perspectives. AAPS PharmSciTech  2022,23(5),152","journal-title":"AAPS PharmSciTech"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","volume":"32","author":"Noble G.T.","year":"2014","unstructured":"Noble G.T.; Stefanick J.F.; Ashley J.D.; Kiziltepe T.; Bilgicer B.; Ligand-targeted liposome design: Challenges and fundamental considerations. Trends Biotechnol  2014,32(1),32-45","journal-title":"Trends Biotechnol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"Liu P.","year":"2022","unstructured":"Liu P.; Chen G.; Zhang J.; A Review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules  2022,27(4),1372","journal-title":"Molecules"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"Lou J.","year":"2023","unstructured":"Lou J.; Duan H.; Qin Q.; Advances in oral drug delivery systems: Challenges and opportunities. Pharmaceutics  2023,15(2),484","journal-title":"Pharmaceutics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"Bozzuto G.","year":"2015","unstructured":"Bozzuto G.; Molinari A.; Liposomes as nanomedical devices. Int J Nanomedicine  2015,10,975-999","journal-title":"Int J Nanomedicine"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainresbull.2019.07.015","volume":"152","author":"Bruch G.E.","year":"2019","unstructured":"Bruch G.E.; Fernandes L.F.; Bassi B.L.T.; Liposomes for drug delivery in stroke. Brain Res Bull  2019,152,246-256","journal-title":"Brain Res Bull"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"Large D.E.","year":"2021","unstructured":"Large D.E.; Abdelmessih R.G.; Fink E.A.; Auguste D.T.; Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev  2021,176,113851","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=24","first-page":"61","volume":"11","author":"Woodley J.F.","year":"1994","unstructured":"Woodley J.F.; Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst  1994,11(2-3),61-95","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","volume":"9","author":"He H.","year":"2019","unstructured":"He H.; Lu Y.; Qi J.; Zhu Q.; Chen Z.; Wu W.; Adapting liposomes for oral drug delivery. Acta Pharm Sin B  2019,9(1),36-48","journal-title":"Acta Pharm Sin B"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"116255","DOI":"10.1016\/j.foodres.2025.116255","volume":"208","author":"Yi X.","year":"2025","unstructured":"Yi X.; Chen Y.; Gao X.; Gao S.; Xia G.; Shen X.; Enhancement of digestive stability in curcumin-loaded liposomes via glycolipids: An analysis in vitro and in vivo. Food Res Int  2025,208,116255","journal-title":"Food Res Int"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","volume":"81","author":"Bernkop-Schn\u00fcrch A.","year":"2012","unstructured":"Bernkop-Schn\u00fcrch A.; D\u00fcnnhaupt S.; Chitosan-based drug delivery systems. Eur J Pharm Biopharm  2012,81(3),463-469","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/polym15030526","volume":"15","author":"Picos-Corrales L.A.","year":"2023","unstructured":"Picos-Corrales L.A.; Morales-Burgos A.M.; Ruelas-Leyva J.P.; Chitosan as an outstanding polysaccharide \u0131mproving health-commodities of humans and environmental protection. Polymers  2023,15(3),526","journal-title":"Polymers"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"106291","DOI":"10.1016\/j.fbio.2025.106291","volume":"66","author":"Zhang T.","year":"2025","unstructured":"Zhang T.; Yu H.; Li C.; Study of the interaction between polysaccharides and liposomes based on low-field nuclear magnetic resonance. Food Biosci  2025,66,106291","journal-title":"Food Biosci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jconrel.2022.10.005","volume":"351","author":"Elkomy M.H.","year":"2022","unstructured":"Elkomy M.H.; Ali A.A.; Eid H.M.; Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. J Control Release  2022,351,923-940","journal-title":"J Control Release"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4155\/tde.15.69","volume":"6","author":"Wu W.","year":"2015","unstructured":"Wu W.; Lu Y.; Qi J.; Oral delivery of liposomes. Ther Deliv  2015,6(11),1239-1241","journal-title":"Ther Deliv"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"106623","DOI":"10.1016\/j.jddst.2025.106623","volume":"105","author":"Alghareeb S.","year":"2025","unstructured":"Alghareeb S.; Ekenna I.; Asare-Addo K.; Conway B.R.; Adebisi A.O.; Chitosan nanoparticles for nasal drug delivery. J Drug Deliv Sci Technol  2025,105,106623","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3390\/polym15153150","volume":"15","author":"Kumar A.","year":"2023","unstructured":"Kumar A.; Yadav S.; Pramanik J.; Chitosan-based composites: Development and perspective in food preservation and biomedical applications. Polymers  2023,15(15),3150","journal-title":"Polymers"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2478\/v10007-007-0005-9","volume":"57","author":"Patel V.","year":"2007","unstructured":"Patel V.; Prajapati B.; Patel M.; Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride. Acta Pharm  2007,57(1),61-72","journal-title":"Acta Pharm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1515\/znc-2023-0181","volume":"79","author":"Das U.","year":"2024","unstructured":"Das U.; Kapoor D.U.; Singh S.; Prajapati B.G.; Unveiling the potential of chitosan-coated lipid nanoparticles in drug delivery for management of critical illness: A review. Z Naturforsch C J Biosci  2024,79(5-6),107-124","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jsps.2019.02.008","volume":"27","author":"Alomrani A.","year":"2019","unstructured":"Alomrani A.; Badran M.; Harisa G.I.; The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer. Saudi Pharm J  2019,27(5),603-611","journal-title":"Saudi Pharm J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.12991\/201014455","volume":"2","author":"Erdem S.","year":"2010","unstructured":"Erdem S.; T\u00fcrko\u01e7lu M.; Glycyl-l-histidyl-l-liysine-Cu(2) loaded liposome formulations. Marmara Pharm J  2010,2(14),91-97","journal-title":"Marmara Pharm J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"109557","DOI":"10.1016\/j.compositesb.2021.109557","volume":"231","author":"Hosseini S.M.","year":"2022","unstructured":"Hosseini S.M.; Abdouss M.; Mazinani S.; Soltanabadi A.; Kalaee M.; Modified nanofiber containing chitosan and graphene oxide-magnetite nanoparticles as effective materials for smart wound dressing. Compos, Part B Eng  2022,231,109557","journal-title":"Compos, Part B Eng"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.foodhyd.2018.04.040","volume":"83","author":"Zhou F.","year":"2018","unstructured":"Zhou F.; Xu T.; Zhao Y.; Chitosan-coated liposomes as delivery systems for improving the stability and oral bioavailability of acteoside. Food Hydrocoll  2018,83,17-24","journal-title":"Food Hydrocoll"},{"key":"ref=40","year":"2003","unstructured":"Nadolol.  Available from:  https:\/\/www.waters.com\/nextgen\/es\/es\/library\/application-notes\/2003\/nadolol.html?srsltid=AfmBOoq3uaqHdRwkW0mfcA_x6_5v3EQmd0cdM-LhuESIx_5nFFUcjVkR2003"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jconrel.2013.10.011","volume":"172","author":"Gradauer K.","year":"2013","unstructured":"Gradauer K.; Barthelmes J.; Vonach C.; Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release  2013,172(3),872-878","journal-title":"J Control Release"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/02652048.2015.1094532","volume":"33","author":"\u00dcst\u00fcnda\u011f Okur N.","year":"2016","unstructured":"\u00dcst\u00fcnda\u011f Okur N.; Yurdasiper A.; G\u00fcndo\u011fdu E.; Homan G.E.; Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: Polyethylene glycol versus chitosan oligosaccharide lactate. J Microencapsul  2016,33(1),30-42","journal-title":"J Microencapsul"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1039\/C4TB00876F","volume":"2","author":"Nguyen T.X.","year":"2014","unstructured":"Nguyen T.X.; Huang L.; Liu L.; Elamin Abdalla A.M.; Gauthier M.; Yang G.; Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. J Mater Chem B Mater Biol Med  2014,2(41),7149-7159","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.12991\/mpj.201620065652","volume":"20","author":"\u0130lem-\u00d6zdemir D.","year":"2016","unstructured":"\u0130lem-\u00d6zdemir D.; G\u00fcndo\u011fdu E.; Ekinci M.; A\u015f\u0131ko\u011flu M.; Radioactive permeability studies of doxycycline hyclate from microemulsion and solution. Marmara Pharm J  2016,20(2),116-121","journal-title":"Marmara Pharm J"},{"key":"ref=45","first-page":"45","volume":"41","author":"Erkeko\u011flu P.","year":"2021","unstructured":"Erkeko\u011flu P.; Baydar T.; G\u00fcncel in vitro sitotoksisite testleri. Hacettepe Univ J Fac Pharm  2021,41(1),45-63","journal-title":"Hacettepe Univ J Fac Pharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/s41598-020-63894-9","volume":"10","author":"Shariare M.H.","year":"2020","unstructured":"Shariare M.H.; Rahman M.; Lubna S.R.; Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model. Sci Rep  2020,10(1),6938","journal-title":"Sci Rep"},{"key":"ref=47","first-page":"325","volume":"46","author":"Nazl\u0131 H.","year":"2021","unstructured":"Nazl\u0131 H.; Mesut B.; \u00d6zsoy Y.; Pharmaceutical approaches for low solubility agents and solubility of aprepitant. J Pharm Sci  2021,46(3),325-344","journal-title":"J Pharm Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4274\/tjps.83803","volume":"15","author":"\u00c7oban \u00d6.","year":"2018","unstructured":"\u00c7oban \u00d6.; De\u011fim Z.; Development of Nanocochleates containing erlotinib HCl and dexketoprofen trometamol and evaluation of \u0131n vitro characteristic properties. Turk J Pharm Sci  2018,15(1),16-21","journal-title":"Turk J Pharm Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ddr.21530","volume":"80","author":"\u00c7oban \u00d6.","year":"2019","unstructured":"\u00c7oban \u00d6.; De\u011fim Z.; Y\u0131lmaz \u015e.; Alt\u0131nta\u015f L.; Arsoy T.; S\u00f6zmen M.; Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug Dev Res  2019,80(5),556-565","journal-title":"Drug Dev Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"120571","DOI":"10.1016\/j.ijpharm.2021.120571","volume":"601","author":"Guimar\u00e3es D.","year":"2021","unstructured":"Guimar\u00e3es D.; Cavaco-Paulo A.; Nogueira E.; Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm  2021,601,120571","journal-title":"Int J Pharm"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1208\/s12249-010-9559-9","volume":"12","author":"Channarong S.","year":"2011","unstructured":"Channarong S.; Chaicumpa W.; Sinchaipanid N.; Mitrevej A.; Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: The improvement of Peyer\u2019s patch targeting using a polyplex-loaded liposomes. AAPS PharmSciTech  2011,12(1),192-200","journal-title":"AAPS PharmSciTech"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.1016\/j.onano.2022.100064","volume":"8","author":"Nguyen V.H.","year":"2022","unstructured":"Nguyen V.H.; Thuy V.N.; Van T.V.; Dao A.H.; Lee B.J.; Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration. OpenNano  2022,8,100064","journal-title":"OpenNano"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1021\/jf200094m","volume":"59","author":"Rao J.","year":"2011","unstructured":"Rao J.; McClements D.J.; Formation of flavor oil microemulsions, nanoemulsions and emulsions: Influence of composition and preparation method. J Agric Food Chem  2011,59(9),5026-5035","journal-title":"J Agric Food Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/1750-3841.16116","volume":"87","author":"Li X.","year":"2022","unstructured":"Li X.; Tang C.; Salama M.; Encapsulation efficiency and oral delivery stability of chitosan\u2013liposome\u2010encapsulated immunoglobulin Y. J Food Sci  2022,87(4),1708-1720","journal-title":"J Food Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.nano.2017.08.005","volume":"13","author":"Grigoras A.G.","year":"2017","unstructured":"Grigoras A.G.; Polymer-lipid hybrid systems used as carriers for insulin delivery. Nanomedicine  2017,13(8),2425-2437","journal-title":"Nanomedicine"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/pr9030445","volume":"9","author":"Sebaaly C.","year":"2021","unstructured":"Sebaaly C.; Trifan A.; Sieniawska E.; Greige-Gerges H.; Chitosan-coating effect on the characteristics of liposomes: A focus on bioactive compounds and essential oils: A review. Processes  2021,9(3),445","journal-title":"Processes"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"100265","DOI":"10.1016\/j.hybadv.2024.100265","volume":"6","author":"Das A.","year":"2024","unstructured":"Das A.; Ghosh S.; Pramanik N.; Chitosan biopolymer and its composites: Processing, properties and applications- A comprehensive review. Hybrid Advances  2024,6,100265","journal-title":"Hybrid Advances"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"34554","DOI":"10.1016\/j.heliyon.2024.e34554","volume":"10","author":"Han J.","year":"2024","unstructured":"Han J.; Meade J.; Devine D.; Sadeghpour A.; Rappolt M.; Goycoolea F.M.; Chitosan-coated liposomal systems for delivery of antibacterial peptide LL17-32 to Porphyromonas gingivalis. Heliyon  2024,10(14),34554","journal-title":"Heliyon"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"106153","DOI":"10.1016\/j.jddst.2024.106153","volume":"101","author":"Ahad A.","year":"2024","unstructured":"Ahad A.; Raish M.; Bin Jardan Y.A.; Al-Mohizea A.M.; Al-Jenoobi F.I.; Chitosan-tethered liposomes for sinapic acid delivery. J Drug Deliv Sci Technol  2024,101,106153","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijpharm.2017.12.044","volume":"537","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Yang T.; Wei S.; Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. Int J Pharm  2018,537(1-2),245-256","journal-title":"Int J Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","volume":"12","author":"Andra V.V.S.N.L.","year":"2022","unstructured":"Andra V.V.S.N.L.; Pammi S.V.N.; Bhatraju L.V.K.P.; Ruddaraju L.K.; A Comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. Bionanoscience  2022,12(1),274-291","journal-title":"Bionanoscience"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.carbpol.2016.10.063","volume":"157","author":"Alavi S.","year":"2017","unstructured":"Alavi S.; Haeri A.; Dadashzadeh S.; Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery. Carbohydr Polym  2017,157,991-1012","journal-title":"Carbohydr Polym"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1039\/D1JA00459J","volume":"37","author":"Wr\u00f3blewska A.M.","year":"2022","unstructured":"Wr\u00f3blewska A.M.; Samsonowicz-G\u00f3rski J.; Kami\u0144ska E.; Drozd M.; Matczuk M.; Optimization of a CE-ICP-MS\/MS method for the investigation of liposome\u2013cisplatin nanosystems and their interactions with transferrin. J Anal At Spectrom  2022,37(7),1442-1449","journal-title":"J Anal At Spectrom"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08982104.2020.1820521","volume":"31","author":"Gopi S.","year":"2021","unstructured":"Gopi S.; Balakrishnan P.; Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability. J Liposome Res  2021,31(4),356-364","journal-title":"J Liposome Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"126281","DOI":"10.1016\/j.ijbiomac.2023.126281","volume":"252","author":"Li K.","year":"2023","unstructured":"Li K.; Zhong W.; Li P.; Ren J.; Jiang K.; Wu W.; Antibacterial mechanism of lignin and lignin-based antimicrobial materials in different fields. Int J Biol Macromol  2023,252,126281","journal-title":"Int J Biol Macromol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"114845","DOI":"10.1016\/j.bios.2022.114845","volume":"219","author":"Siva S.","year":"2023","unstructured":"Siva S.; Jin J.O.; Choi I.; Kim M.; Nanoliposome based biosensors for probing mycotoxins and their applications for food: A review. Biosens Bioelectron  2023,219,114845","journal-title":"Biosens Bioelectron"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2009.08.015","volume":"140","author":"Yin Y.M.","year":"2009","unstructured":"Yin Y.M.; Cui F.D.; Mu C.F.; Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation. J Control Release  2009,140(2),86-94","journal-title":"J Control Release"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"Immordino M.L.","year":"2006","unstructured":"Immordino M.L.; Dosio F.; Cattel L.; Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine  2006,1(3),297-315","journal-title":"Int J Nanomedicine"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","volume":"449","author":"Chen D.","year":"2013","unstructured":"Chen D.; Xia D.; Li X.; Comparative study of Pluronic\u00ae F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int J Pharm  2013,449(1-2),1-9","journal-title":"Int J Pharm"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/08982104.2020.1849280","volume":"31","author":"Sa\u011f\u0131ro\u011flu A.A.","year":"2021","unstructured":"Sa\u011f\u0131ro\u011flu A.A.; Chitosan-coated liposome-containing carbamazepine and coenzyme Q10: Design, optimization and evaluation. J Liposome Res  2021,31(4),389-398","journal-title":"J Liposome Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.3390\/ijms20194706","volume":"20","author":"Le N.T.T.","year":"2019","unstructured":"Le N.T.T.; Cao V.D.; Nguyen T.N.Q.; Le T.T.H.; Tran T.T.; Hoang Thi T.T.; Soy lecithin-derived liposomal delivery systems: Surface modification and current applications. Int J Mol Sci  2019,20(19),4706","journal-title":"Int J Mol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/B978-0-12-804017-1.00004-2","author":"Mili\u0107 J.","year":"2017","unstructured":"Mili\u0107 J.; \u010calija B.; Dordevi\u0107 S.M.; Diversity and functionality of excipients for micro\/nanosized drug carriers. microsized nanosized carriers. Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs  2017,95-132","journal-title":"Microsized and Nanosized Carriers for Nonsteroidal Anti-Inflammatory Drugs"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.fct.2018.01.017","volume":"113","author":"Kaddah S.","year":"2018","unstructured":"Kaddah S.; Khreich N.; Kaddah F.; Charcosset C.; Greige-Gerges H.; Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol  2018,113,40-48","journal-title":"Food Chem Toxicol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2013.05.023","volume":"452","author":"Jeon H.S.","year":"2013","unstructured":"Jeon H.S.; Seo J.E.; Kim M.S.; A retinyl palmitate-loaded solid lipid nanoparticle system: Effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo. Int J Pharm  2013,452(1-2),311-320","journal-title":"Int J Pharm"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"38777","DOI":"10.1016\/j.heliyon.2024.e38777","volume":"10","author":"Bhat U.M.","year":"2024","unstructured":"Bhat U.M.; Khan N.A.; Raza S.N.; Ciprofloxacin hydrochloride-loaded ocular silk fibroin liposomes: Formulation, characterisation, in vitro cytotoxicity, and antimicrobial activity. Heliyon  2024,10(22),38777","journal-title":"Heliyon"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijpharm.2015.05.006","volume":"489","author":"Cui M.","year":"2015","unstructured":"Cui M.; Wu W.; Hovgaard L.; Lu Y.; Chen D.; Qi J.; Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin. Int J Pharm  2015,489(1-2),277-284","journal-title":"Int J Pharm"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2174\/1567201820666230214091509","volume":"21","author":"Okur N.\u00dc.","year":"2024","unstructured":"Okur N.\u00dc.; \u00c7a\u011flar E.\u015e.; Kaynak M.S.; Diril M.; \u00d6zcan S.; Karasulu H.Y.; Enhancing oral bioavailability of domperidone maleate: Formulation, in vitro permeability evaluation \u0131n-Caco-2 cell monolayers and in situ rat\u0131ntestinal permeability studies. Curr Drug Deliv  2024,21(7),1010-1023","journal-title":"Curr Drug Deliv"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"154110","DOI":"10.1016\/j.phymed.2022.154110","volume":"101","author":"Xu Z.","year":"2022","unstructured":"Xu Z.; Hou Y.; Sun J.; Deoxycholic acid-chitosan coated liposomes combined with in situ colonic gel enhances renal fibrosis therapy of emodin. Phytomedicine  2022,101,154110","journal-title":"Phytomedicine"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"Danaei M.","year":"2018","unstructured":"Danaei M.; Dehghankhold M.; Ataei S.; Impact of particle size and polydispersity \u0131ndex on the clinical applications of lipidic nanocarrier systems. Pharmaceutics  2018,10(2),57","journal-title":"Pharmaceutics"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2012.04.007","volume":"430","author":"Qiang F.","year":"2012","unstructured":"Qiang F.; Shin H.J.; Lee B.J.; Han H.K.; Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm  2012,430(1-2),161-166","journal-title":"Int J Pharm"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tifs.2019.06.001","volume":"90","author":"Montes C.","year":"2019","unstructured":"Montes C.; Villase\u00f1or M.J.; R\u00edos \u00c1.; Analytical control of nanodelivery lipid-based systems for encapsulation of nutraceuticals: Achievements and challenges. Trends Food Sci Technol  2019,90,47-62","journal-title":"Trends Food Sci Technol"},{"key":"ref=82","first-page":"313","author":"Mudalige T.","year":"2019","unstructured":"Mudalige T.; Qu H.; Van Haute D.; Ansar S.M.; Paredes A.; Ingle T.;  Characterization of nanomaterials: Tools and challenges  2019,313-353","journal-title":"Characterization of nanomaterials: Tools and challenges"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"135244","DOI":"10.1016\/j.colsurfa.2024.135244","volume":"703","author":"Engelhardt M.B.","year":"2024","unstructured":"Engelhardt M.B.; Sugimoto T.; Papastavrou G.; Kobayashi M.; Electrophoretic mobility of nanoparticle aggregates: Independence from aggregate size. Colloids Surf A Physicochem Eng Asp  2024,703,135244","journal-title":"Colloids Surf A Physicochem Eng Asp"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128401910250706133608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243646\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128401910250706133608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:23:29Z","timestamp":1767090209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243646\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128401910250706133608","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}